About Peter Lawrence
Form D filings for Cardurion Pharmaceuticals from 2021 to 2024 list Peter Lawrence as president and chief executive officer, director.
Peter Lawrence first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Peter Lawrence in the role, so the role may have started earlier or lasted longer.
Cardurion Pharmaceuticals, Inc.
President and Chief Executive Officer, director
2021 – 2024 · Burlington, MA
Key Colleagues at Startups
The people Peter Lawrence works with at each company, as listed on that company's latest Form D.
Cardurion Pharmaceuticals, Inc. · Form D, Jul 24, 2024
ER
Evan Rachlin
Director
Jeb Keiper
Director
MM
Michael Mendelsohn
Executive officer and director
DL
Daniel Lynch
Director
ER
Emma Reeve
Director
EM
Edward Mathers
Director
AK
Adam Koppel
Director
ND
Nicholas Downing
Director